when the amount of the reduced glutathione for injection is 1.0g, the formula components are as follows: 1.0g of reduced glutathione, adjusting the pH value to 6.0-7.0 by using 10% sodium hydroxide solution, and adding 3.3g of water for injection
Statistical values for ototoxin were omitted from figure legends because it is established that they cause a dose-dependent decrease in hair cell survival, in other words, we know that a dose-response curve for neomycin only will be statistically significant
It is hypothesized that the mechanism of action of NAC may consisted of blocking the viral infection and the consequent cytokine storm
84,85,86 Most cancer cells overexpress IDO, and the level of kynurenine in the microenvironment is associated with poor prognosis in multiple solid and hematological malignancies
Hormone Replacement Therapy Women can lose up to 30% of skin collagen in the first 5 years of menopause34 and may also experience a 0.55% loss of skin elasticity each year.35 A double-blind RCT evaluating the effects of hormone replacement therapy (HRT) (2mg 17B estradiol/10mg dydrogesterone) on the skin of 40 postmenopausal women found an increase in skin thickness, hydration, and elasticity after 7 months of treatment.36 Another study (n=55) showed that postmenopausal women on HRT with estrogen and testosterone had 48% higher collagen content in the skin.37 A similar study (n=25) reported significantly higher type III collagen content in women treated with estradiol and testosterone implants.38 Likewise, a large prospective study involving 176 women found a 5.2% increase in skin elasticity after 12 months of HRT.35 Other authors have also reported a significant increase in skin viscoelasticity (n=200) in women on HRT.39 Nonetheless, a large RCT (n=485) detected no differences in facial wrinkles or skin laxity between postmenopausal women treated with HRT and those treated with placebo.40 Elderly individuals may show low levels of growth hormones and also experience a dramatic decrease in skin thickness.41 Two studies have reported increased epidermal and dermal thickness in individuals with deficient growth hormone levels treated with growth hormone therapy.41,42 Potential adverse effects include gynecomastia and carpal tunnel syndrome
IGF-1 levels can triple without producing noticeable symptoms, silently increasing cancer risk
